Premium
Safety and efficacy of dupilumab in a patient with severe atopic dermatitis and HIV infection, with 15 months of follow‐up
Author(s) -
Romagnuolo M.,
Angileri L.,
Tavecchio S.,
Marzano A. V.,
Ferrucci S.
Publication year - 2020
Publication title -
clinical and experimental dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.587
H-Index - 78
eISSN - 1365-2230
pISSN - 0307-6938
DOI - 10.1111/ced.14278
Subject(s) - dupilumab , atopic dermatitis , medicine , dermatology , human immunodeficiency virus (hiv) , immunopathology , immunology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom